SPMGX
Price
$8.23
Change
+$0.14 (+1.73%)
Updated
Dec 20 closing price
SPMHX
Price
$8.55
Change
+$0.14 (+1.66%)
Updated
Dec 20 closing price
Ad is loading...

SPMGX vs SPMHX

Header iconSPMGX vs SPMHX Comparison
Open Charts SPMGX vs SPMHXBanner chart's image
Invesco SteelPath MLP Alpha R
Price$8.23
Change+$0.14 (+1.73%)
VolumeN/A
CapitalizationN/A
Invesco SteelPath MLP Alpha R5
Price$8.55
Change+$0.14 (+1.66%)
VolumeN/A
CapitalizationN/A
SPMGX vs SPMHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SPMGX vs. SPMHX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SPMGX is a Buy and SPMHX is a Buy.

FUNDAMENTALS
Fundamentals
SPMGX (1.18B) and SPMHX (1.18B) have equal amount of cash in the bank . SPMGX (5.29) and SPMHX (5.12) have matching dividends . SPMGX was incepted earlier than SPMHX: SPMGX (6 years) vs SPMHX (6 years). SPMGX (32.00) and SPMHX (32.00) have comparable annual turnover. SPMGX has a lower initial minimum investment than SPMHX: SPMGX (1000) vs SPMHX (1000000). SPMHX (40.05) and SPMGX (39.39) have marching annual gain over last year. SPMHX return over 5 years is better than : 121.26 vs. SPMGX (115.28).
SPMGXSPMHXSPMGX / SPMHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years6 years-
Gain YTD38.50539.18998%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.18B1.18B100%
Annual Yield % from dividends5.295.12103%
Returns for 1 year39.3940.0598%
Returns for 3 years122.38125.8397%
Returns for 5 years115.28121.2695%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HSDT0.910.43
+89.58%
Helius Medical Technologies
MLYS12.340.51
+4.31%
Mineralys Therapeutics
SOL1.820.03
+1.68%
Emeren Group Ltd
MWA22.940.07
+0.31%
Mueller Water Products
SRPT118.97-0.50
-0.42%
Sarepta Therapeutics